US Stock MarketDetailed Quotes
ISPC iSpecimen
- 2.920
- -0.530-15.36%
Close Dec 13 16:00 ET
- 2.980
- +0.060+2.05%
Post 19:54 ET
2.81MMarket Cap-0.16P/E (TTM)
4.660High2.760Low2.64MVolume3.930Open3.450Pre Close10.39MTurnover309.67%Turnover RatioLossP/E (Static)962.64KShares12.20052wk High0.60P/B2.48MFloat Cap2.76052wk Low--Dividend TTM850.99KShs Float579.598Historical High--Div YieldTTM55.07%Amplitude2.760Historical Low3.942Avg Price1Lot Size
About iSpecimen Company
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.
Company Profile
SymbolISPC
Company NameiSpecimen
Listing DateJun 17, 2021
Issue Price8.00
Founded2009
CEOMr. Robert Bradley Lim
MarketNASDAQ
Employees53
Fiscal Year Ends12-31
Address8 Cabot Road,Suite 1800
CityWoburn
ProvinceMassachusetts
CountryUnited States of America
Zip Code01801
Phone1-781-301-6700
Websitehttp://www.ispecimen.com
Company Executives
- Name
- Position
- Salary
- Katharyn Field
- Chairman of the Board
- --
- Avtar Dhaliwal
- Independent Director
- --
- George Scholl
- Independent Director
- 21.09K
- Richard Paolone
- Independent Director
- --
- John L. Brooks, III
- Independent Director
- 34.93K
- Robert Bradley Lim
- Chief Executive Officer and Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data